The imaging mode includes multi-channel wide-field fluorescence and brightfield formats, using high-intensity LED light sources and onboard filter cubes. Automated XY stage, autofocus and autoexposure increase imaging throughput compared to manual microscopy systems. Multi-mode detection uses patented Hybrid Technology™, which combines high sensitivity filter-based detection and flexible monochromator-based detection for unmatched assay versatility now and in the future. Additionally, Cytation3 offers temperature control up to 45 °C, gas control and variable shaking to enhance live cell-based assay efficiency.
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a "Think Possible" approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. As such, they are often honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, North American New Product Innovation Award for Workflow Solutions in Life Sciences and Drug Discovery Product of the Year – Scientists' Choice Award.